MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00543595

Enrollment

154

Registered

2007-10-15

Start date

2004-08-31

Completion date

2005-05-31

Last updated

2015-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Metabolic Syndrome

Brief summary

This study will test the safety and effectiveness of MK0916 in patients with Type 2 Diabetes Mellitus and Metabolic Syndrome. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Interventions

DRUGMK0916

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Have Type 2 Diabetes * 18 to 65 years of age

Exclusion criteria

* History of Type 1 Diabetes Mellitus * Have been treated with insulin in the past 8 weeks * On a weight loss program and have ongoing weight loss * Taking weight loss medication * Have had surgery requiring general anesthesia in the past 30 days or have a planned surgery * Have taken another investigational drug in the last 8 weeks * Have active liver disease * Have a history of major surgery involving gastric or intestinal bypass

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026